Streetbeat News

Products Services

KRTX

Karuna Therapeutics, Inc. (NASDAQ:KRTX) announced that the FDA has accepted its New Drug Application for KarXT for the treatment of schizophrenia in adults. The PDUFA date is set for September 26, 2024, which is the target action date for the FDA to make a decision on the drug's approval.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:31 am

AMZN

Amazon has introduced a new AI chatbot named Q, aimed at challenging Microsoft and Google in the productivity software domain. Q is designed for business operations and is currently in a preview version, with a full version costing $20-$25 per user per month. It will assist with AWS capabilities and troubleshooting, and can be integrated with apps like Salesforce's Slack and developers' text-editing applications.

Portfolio Pulse from Benzinga Neuro

November 29, 2023 | 11:25 am

LLY

UTHR

United Therapeutics has extended its exclusive license agreement with Eli Lilly for the marketing, promotion, and sale of Adcirca (tadalafil) tablets in the US until December 31, 2026. The agreement, which was set to expire on December 31, 2023, allows United Therapeutics to continue commercializing Adcirca for pulmonary hypertension treatment. Other terms of the agreement remain unchanged.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:14 am

KHC

The Kraft Heinz Not Company LLC, a joint venture between Kraft Heinz (NASDAQ:KHC) and NotCo, has launched KRAFT NotMac&Cheese, marking the first plant-based version of KRAFT Mac & Cheese in the U.S. This is the third plant-based food innovation from the collaboration within a year, reflecting the companies' commitment to expanding their plant-based food offerings.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:03 am

CVNA

Carvana, an online used car retailer, has expanded its same-day delivery services to residents of Central Florida, enhancing the convenience for customers in the region and potentially increasing the company's market penetration.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:02 am

KBR

PT Pupuk Sriwidjaja has selected KBR's Purifier technology for a new grassroots ammonia plant in Indonesia. KBR will provide a technology license, proprietary engineering design, proprietary equipment, and catalyst for the plant. The financial terms of the contract were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:01 am

BEEM

Beam Global has announced ongoing orders for its EV ARC solar-powered EV charging systems from various California state agencies. This indicates a sustained demand for Beam's products within the state sector, potentially signaling growth in the company's public sector sales.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 11:01 am

TSLA

The Biden administration is considering providing temporary relief to automakers from the stringent EV tax credit rules that are based on the sourcing of materials from 'foreign entities of concern,' such as China. This move could affect the amount of tax credit EV purchasers receive, with full compliance resulting in a $7,500 credit and partial compliance in a $3,500 credit. Tesla Inc has informed customers that the tax credit for its Model 3 could be reduced after this year. The Treasury Department is expected to issue guidance on the matter soon.

Portfolio Pulse from Anan Ashraf

November 29, 2023 | 10:49 am

CABA

CLCO

FTCH

LESL

LVS

OKTA

PHG

VERV

Leslie's, Inc. reported mixed Q4 results with revenue exceeding estimates but earnings per share falling short, causing a 15% pre-market drop. Verve Therapeutics announced a public offering and private placement, leading to an 11.2% pre-market decline. Cabaletta Bio continued to fall after FDA concerns over CAR T cell therapies. Okta disclosed a data breach affecting all support system users. Cool Company reported Q3 results, contributing to a pre-market dip. Las Vegas Sands announced a stock offering by its principal stockholder. Philips faced FDA safety concerns with its CPAP machines. Farfetch delayed its Q3 financial results announcement.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 10:48 am

UA

Kevin Plank, founder of Under Armour, Inc. (NYSE:UA), shares his journey from starting in his grandmother's basement to building a $5 billion empire. Plank's initial capital came from his college rose business and a $40,000 credit card opportunity. Under Armour's growth from $17,000 in sales in 1996 to $5.74 billion in revenue in FY2023 is highlighted, with a significant portion of sales coming from apparel. The company has a strong direct-to-consumer presence and a brand relationship with NBA star Stephen Curry. Under Armour is part of the S&P 400 MidCap Index and its stock closed up 0.94% at $7.54.

Portfolio Pulse from Shanthi Rexaline

November 29, 2023 | 10:31 am